Minted: - / 5000

2707 Vismodegib
7a1e6c8f32a28a19ab945afe3ecaf1cdda585b8fef2f54093dec1833d881e99d

Properties

Background

Yellow
Bottle

Green
Cap

Blue
Syringe

Purple
Bubbles
No
Drops
Yes
Label
-

Chemistry

Formula
C19H14Cl2N2O3S
Carbon
19
Polarity
Neutral

Vismodegib (trade name Erivedge ) is a drug for the treatment of basal-cell carcinoma (BCC). The approval of vismodegib on January 30, 2012, represents the first Hedgehog signaling pathway targeting agent to gain U.S. Food and Drug Administration (FDA) approval. The drug is also undergoing clinical trials for metastatic colorectal cancer, small-cell lung cancer, advanced stomach cancer, pancreatic cancer, medulloblastoma and chondrosarcoma . The drug was developed by the biotechnology/pharmaceutical company Genentech.

From Wikipedia, the free encyclopedia. License: CC BY-SA.